Ayala Pharmaceuticals Income
What is the Income of Ayala Pharmaceuticals?
The Income of Ayala Pharmaceuticals Inc. is -$15.38
What is the definition of Income?
Net income available for common shareholders equals net income minus preferred dividends paid.
ttm (trailing twelve months)
Net income available to common shareholders are the profits remaining after the company pays all of its suppliers, employees, service providers, creditors, and preferred shareholders. In other words, this is revenue less all expenses and preferred dividends. The number measures common shareholders' claim on the company's cash flows.
Income of companies in the Health Care sector on NASDAQ compared to Ayala Pharmaceuticals
What does Ayala Pharmaceuticals do?
advaxis (nasdaq: adxs) is a late -stage biotechnology company developing multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer. the advaxis technology, using bioengineered live attenuated bacteria, listeria monocytogenes (lm), actively suppresses key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack.
Companies with income similar to Ayala Pharmaceuticals
- Dolphin Entertainment has Income of -$15.42
- Gujarat Sidhee Cement has Income of -₨15.42
- MAX21 AG has Income of -€15.42
- The Supreme Cannabis Co has Income of -CAD$15.40
- Trevali Mining has Income of -$15.40
- The Supreme Cannabis has Income of -CAD$15.40
- Ayala Pharmaceuticals has Income of -$15.38
- GWR has Income of -AUD$15.38
- Cassava Sciences Inc has Income of -$15.37
- Beijing Capital Land has Income of -¥15.37
- Cadillac Ventures has Income of -CAD$15.36
- Avinger Inc has Income of -$15.34
- Think Research has Income of -CAD$15.33